• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 XPI - CMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 XPI - CMB Back to Search Results
Model Number IMMULITE 2000 XPI - CMB
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/13/2019
Event Type  malfunction  
Manufacturer Narrative
The customer contacted siemens customer care center (ccc).Siemens headquarters support center (hsc) is reviewing the provided results, the instrument files, and the error logs.The cause for the discordant, falsely elevated cmb sample result is unknown.Siemens is investigating the issue.
 
Event Description
One discordant, falsely elevated creatine kinase isoenzyme - mb (cmb) result was obtained on immulite 2000 xpi instrument.The initial result was not reported to the physician(s).The same sample was repeated using the same immulite 2000 xpi instrument.The repeat result was considered correct and reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely elevated cmb result.
 
Manufacturer Narrative
Siemens filed initial mdr 2432235-2019-00312 on 5-sep-2019.Additional information (15-oct-2019): siemens headquarters support center (hsc) has reviewed the information provided by the customer.Hsc observed that the original instrument was swapped out to a new immulite 2000 xpi instrument after several repair attempts.The issue was not resolved after the instrument replacement which ruled out a hardware issue.Siemens field application specialist (fas) was dispatched to the customer site to observe the sample handling process for 5 days and found several issues.Fas provided proper sample handling recommendations to the customer.No product performance issue was identified.No other issues have been reported by the customer post fas visit and the actions performed resolved the reported issue.The instrument is performing within specification.No further evaluation of the device is required.Sections h6 and h10 were updated to reflect the additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 XPI - CMB
Type of Device
IMMULITE 2000 XPI - CMB
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy
llanberis, LL55 4EL
EI  LL55 4EL
MDR Report Key8967190
MDR Text Key219482387
Report Number2432235-2019-00312
Device Sequence Number1
Product Code JHX
Combination Product (y/n)N
PMA/PMN Number
K004002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 10/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Model NumberIMMULITE 2000 XPI - CMB
Device Catalogue Number10381033
Device Lot Number253
Was Device Available for Evaluation? No
Date Manufacturer Received10/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age60 YR
-
-